Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

AIMS--To determine the concentrations of interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF alpha) in stools from children. METHODS--Stool samples from 14 healthy children, 32 children with inflammatory bowel disease, and 23 children with acute diarrhoea were emulsified in an equal volume of phosphate buffered saline and then centrifuged to produce a clear supernatant fluid. IL-6 and TNF alpha were measured by enzyme linked immunosorbent assay (ELISA). RESULTS--TNF alpha was detected in the stools of all 14 healthy children (12-130 pg/g stool), but IL-6 was detected only in three. Similar results were seen in children with inactive inflammatory bowel disease. Stool TNF alpha concentrations were raised in samples from children with active inflammatory bowel disease, but in most (11/18) of these samples IL-6 was undetectable. Stool samples contained a heat-labile factor which rapidly destroyed IL-6 immunoreactivity. Most children with diarrhoea had TNF alpha concentrations similar to those of healthy controls and most were also negative for IL-6. Three children with Shigella flexneri infection had extraordinarily high concentrations of both TNF alpha and IL-6 in their stools. CONCLUSIONS--There is constant low grade production of TNF alpha in the intestine of healthy people. Raised values are indicative of mucosal inflammation, but are not specific. Stool IL-6 is of little use in assessing mucosal inflammation because immunoreactivity is rapidly lost in stool samples.

[1]  N. Sheron,et al.  TNFα in stool as marker of intestinal inflammation , 1992, The Lancet.

[2]  M. Kobayashi,et al.  Enhanced mucosal cytokine production in inflammatory bowel disease. , 1992, Gastroenterology.

[3]  J. Schölmerich,et al.  Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. , 1992, Gastroenterology.

[4]  S. Stephens,et al.  Tumour necrosis factor alpha in stool as a marker of intestinal inflammation , 1992, The Lancet.

[5]  C. Hawkey,et al.  High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. , 1991, Gut.

[6]  M. Savage,et al.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. , 1991, Gut.

[7]  D. Spriggs,et al.  Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Cooke,et al.  Tumour necrosis factor‐alpha and interferon‐gamma production measured at the single cell level in normal and inflamed human intestine , 1990, Clinical and experimental immunology.

[9]  L. Leduy,et al.  Interleukin-6 and its receptor are expressed in human intestinal epithelial cells , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[10]  P. Heinrich,et al.  O‐ and N‐glycosylation lead to different molecular mass forms of human monocyte interleukin‐6 , 1989, FEBS letters.

[11]  C W Smith,et al.  Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. , 1988, The Journal of clinical investigation.

[12]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[13]  W. Boldyreff Professor boldyreff and the May, 1933, Session of the American Gastro-Enterological Association , 1934 .

[14]  T. Hirano,et al.  Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. , 1988, Blood.